ASX Announcement ASX: CBL 29 October 2026 QUARTERLY ACTIVITIES REPORT & APPENDIX 4C QUARTER ENDED 30 SEPTEMBER 2026 Highlights • Revenue growth and cash position: Unaudited revenue grew in each month of the quarter and was ahead of the June quarter. Cash receipts were $1.0 million and net...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix is reading this filing.
Earlier from Control Bionics
- Medicare Billing Code Secured for NextLevel Speech Devices
- NeuroStrip secures MHRA registration
- US FDA Registration and Device Listing for NeuroStrip
- Commercial momentum builds across both platform pillars
- Completion of Placement
Follow Control Bionics into a list and get an email when it puts out news.
Follow Control Bionics